Company / Inventory
Viridian Therapeutics, Inc.\DE Inventory History
FY2016-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$64.0K
FY2016
5-year range
-
FY2016-FY2016
Trend
-65.8%
vs FY2015
Sector context
#105 of 105
Health Care
What the data says
Among 105 Health Care companies, Viridian Therapeutics, Inc.\DE is in the bottom 0% for inventory.
Based on SEC 10-K filings.
$64,000 in FY2016.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 105This company $64.0K Sector average $885.3M
▼
-100.0% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $64.0K | -65.8% |
As of FY2016 · SEC 10-K · Updated Jun 30, 2026